BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 19, 2018
View Archived Issues
Ultra-deep sequencing brings new cancer gene insights, and questions
Read More
Turn Therapeutics reports in vivo data for OV-02 for shingles of the eye
Read More
Whole-exome sequencing expands the known causative genes of hereditary distal renal tubular acidosis
Read More
Pivotal phase III KEYNOTE-426 study meets both primary endpoints
Read More
First-in-human study of [11C]JNJ-54173717, a PET tracer for assessing neuroinflammation
Read More
DS Biopharma presents positive results from Advance phase IIb study of oral DS-107
Read More
Jiangsu HengRui studies SHR-1209 in phase I in China
Read More
Midkine as a potential new biomarker of ovarian reserve in PCOS
Read More
Homology Medicines' gene therapy for PKU shows promising preclinical results
Read More
First phase III results from the SAkuraSky study of satralizumab in NMOSD patients
Read More
IPR-166 enhances cognitive performance in a schizophrenia-like mouse model
Read More
NeuroVive drug candidate shows efficacy in model for mitochondrial disease
Read More
Dupilumab results in highly significant improvements in lung function in adolescents with asthma
Read More
Encouraging phase I results for camrelizumab in nasopharyngeal carcinoma
Read More
Efficacy and safety of lurbinectedin in BRCA1/2 mutated or unselected metastatic breast cancer
Read More
PIKfyve inhibitors identified at Nanosyn
Read More
ST Pharm discovers new HIV integrase inhibitors
Read More
Results of phase I trial of epacadostat plus pembrolizumab in advanced solid tumors
Read More
Amgen presents new Mcl-1 inhibitors
Read More
Aelix and Gilead collaborate to study HTI T-cell vaccine with vesatolimod in HIV
Read More
AbbVie and Morphic Therapeutic to develop oral integrin therapeutics for fibrotic diseases
Read More
HERA-CD40L, a hexavalent CD40 agonist, induces antitumor immune responses both in vitro and in vivo
Read More
Increased pyruvate dehydrogenase kinase has key role in pathogenesis of nonalcoholic liver disease
Read More
Nrf2 pathway, novel therapeutic target for the treatment of cognitive impairment in type 1 diabetes
Read More
Novel CNDP1 transgenic mice show protective role of renal carnosine against diabetic nephropathy
Read More
Merrimack terminates SHERLOC study of MM-121 in NSCLC for futility
Read More
Menarini initiates phase Ib study of MEN-1611 for HER2-positive breast cancer
Read More
